ATMP Introductory lectures

The basics of the ATMP field from what are ATMPs to the issues in reimbursing their use

These lectures are being offered as part of the ATMP Sweden/Karolinska Institutet run “Gene and Cell Therapy Product (ATMP) Drug Development” PhD course.

REGISTER to ATMP Sweden 2020 to receive login details.

Preliminary Program;

Monday 16th November

9:35 – 12:00 ATMP technology and classification

The history and science of ATMP – Paul Kingham

What are ATMPs and what are not – Karin Hoogendoorn

13:00 – 14:30 The ATMP drug development chain – Evren Alici

Tuesday 17th November

9:00-12:00 Product development pathway for academic developers – Lilian Walther Jallow, Karolinska Institutet

Wednesday 18th November


Regulatory framework of ATMP manufacturing – Pontus Blomberg

Scaling up and scaling out – Michael Chrobok

Thursday 19th November

9:00-12:00 Commercial considerations for ATMP

Turning a research project to a commercial product – Johan Hyllner

Health economics related to ATMP – Dag Larsson

Ethical aspects in commercialisation of human tissue – Mats Hansson